Self-Expanding Stent Receives CE Mark to Treat Acute Coronary Syndrome
March 8, 2010 – A self-expanding and disconnectable stent today gained CE mark approval in Europe to treat acute coronary syndrome (ACS).
The Stentys platform is designed to ensure optimal apposition of a stent in the critical initial hours and days after an acute myocardial infarction (AMI) procedure, by being continuously applied to the vessel’s internal surface even during thrombus and vessel spasm relief — thereby avoiding malapposition, a significant concern to cardiologists.
For European regulatory approval the company demonstrated how the Stentys stent conforms to a variable vessel anatomy after AMI stenting during the APPOSITION II clinical study. This is a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients, and reviewed using extremely high-resolution OCT (optical coherence tomography) imaging to validate endpoints.
For more information: www.stentys.com
More like this
- Self-Expanding Stent Receives CE Mark to Treat Acute Coronary Syndrome
- Dissolving Stents May Offer New Options in the Next Decade
- New Data Shows Abbott’s Bioabsorbable DES is Absorbed Within Two Years
- Bioresorbable Stent Continues to Show Good Clinical Results
- New Thin Coating Hides Stent, Unblocks Heart Arteries